[Animate Holdings Co., Ltd.] Achieved the goal of 15 million yen! A project aiming to screen “Katashiro” in theaters
*View in browser* *Animate Holdings Co., Ltd.*
Press release: May 14, 2024
**
Achieved the goal of 15 million yen! A project aiming to screen “Katashiro” in theaters
Animate Co., Ltd. is pleased to announce that the Katashiro movie project currently underway on the crowdfunding service “Soreos” has achieved the target amount of 15 million yen.
A project to turn the table talk role-playing game (TRPG) scenario “Katashiro” into a movie and have it screened in theaters began on May 8, 2024 on Animate’s web service “Soleos.”
We received a lot of support from the start, and reached our goal of 15 million yen at around 8:30 pm on May 13th.
This project is ongoing until 23:59 on June 30, 2024.
We look forward to your participation in the project.
Click here for the project page
■Project information
Katashiro movie project
Event period: May 8, 2024, 18:00 to June 30, 2024, 23:59
Venue: Soreosu (https://soreosu.com/projects/katashiromovie
)
Returned items include: Movie pamphlet, name listed on the list of subjects appearing in the movie, credit listed, goods, etc.
*Some return items may be sold out earlier than the event period. *Return items are subject to change without notice.
■Theatrical release information
“Katashiro Replica”
Screening theater: Theater Shinjuku
Release period: June 21, 2024 to June 27, 2024 A work in which one person plays the role of a “patient” will be screened once a day on the late show.
*The schedule is subject to change.
Performer
– Seiji Chihara, Kuru Aizuki
– Kou-chan, Shuo Sango
– Genki Okawa, Kana Takeya
– Miricham, Regrush Lionheart
– Asuka Kurosawa, Aina Aiba
– Katsuya Maikuma, Miko Ishiro
– Akari Saito, Ayumi Okada
– Kazuyuki Kurashima, Neru Amanogawa (test shooting, shown on YouTube) *From left: “Patient role” and “Another patient role”
*The screening date and time of each episode will be announced at a later date.
* “Doctor role” *
– Dism (Author Katashiro)
■What is “Katashiro”?
A one-on-one “interactive” scenario written for TRPG.
By inviting famous streamers and others as players one after another, their thoughts and decisions reveal their “personality” and “charm,” making them extremely popular.
Coupled with the ease of playing the game, which can be played in about an hour, many people in addition to the author shared their gameplay, and it quickly became a movement in the TRPG world. A variety of people are playing, including game commentators, VTubers, streamers, voice actors, comedians, scenario writers, psychiatrists, and more.
The title of the movie version, “Katashiro Replica,” has the meaning of “a replica of the real thing” being “repeated” as a movie. Unlike the streaming and stage version, this work is planned to be a work where you can enjoy the attention to sound that can only be experienced at a movie theater, the fun of going to the movie theater and watching it in the same place, and the excitement of performers you have never seen before.
Comment from Dism, author of “Katashiro”: Please support this unique movie in which the main actors do not have a script.
Mr. Dizm YouTube channel: https://www.youtube.com/@DizmKDC
■What is “Soleos”?
“Soleos” is a place where everyone can support projects related to anime, comics, games, and voice actors. Using a mechanism called crowdfunding, the support amount will be delivered to the project originator. By supporting projects through Soleos, we can create things that fans have wanted but were unable to realize, such as creating works and events that have never been seen before, or creating original goods for voice actors. can. Those who support us can also receive return gifts from the creators of each project.
■Right notation
(C) Katashiro Project
*About details about this release*
https://prtimes.jp/main/html/rd/p/000005352.000016756.html
*Download press release materials*
https://prtimes.jp/im/action.php?run=html&page=releaseimage&company_id=16756&release_id=5352
Unsubscribe HTML email
Copyright © PR TIMES Corporation All Rights Reserved.